MarketWise is rated BUY due to strong billings growth, rising ARPU, and attractive valuation despite a 2Q26 earnings miss driven by revenue timing. MKTW's strategy focuses on upselling higher-value research and tools, resulting in a 73% ARPU increase and a 77% rise in new marketing billings year-over-year. The company maintains a robust 8% dividend yield, no debt, and positive operating cash flow, supporting ongoing share buybacks and dividend stability.
MarketWise is rated BUY, driven by cheap valuations and improving fundamentals as the company targets higher-spending subscribers. MKTW's ARPU surged 76% YoY in 1Q26, with 36% of customers now spending over $2,500, reflecting a strategic shift toward premium clients. The company maintains a strong balance sheet with no debt, a stable 5.3% dividend yield, and ongoing share buybacks.
MarketWise's share price remains disconnected from its rapidly improving business performance. FY26 guidance calls for billings of roughly $290 million and FCF of $45 million, implying a current valuation of just 5.4x FCF. The current dividend yield stands at 12.5% and is set to rise this year, driven by higher FCF generation.
MarketWise is rebounding after a volatile 2024, with new leadership and improved profitability boosting investor confidence. The company benefits from strong retail investor engagement and still-growing demand for independent financial research, positioning it for further market share gains. A clean balance sheet, attractive dividend policy, and discounted valuation versus peers highlight significant upside potential, supported by a conservative DCF analysis.
Despite past issues, MarketWise's recent 33% stock surge and improved operations justify upgrading the rating from ‘hold' to ‘buy' for risk-tolerant investors. Key financial metrics show mixed results: revenue and subscribers declined, but net profits and adjusted operating cash flow improved significantly. Preliminary Q1 2025 results indicate a positive trend in billings, suggesting potential stabilization and early signs of a turnaround.
The business is undergoing a successful turnaround as evidenced by a return to sequential billings growth. Cash flow generation is expected to remain solid, which together with the company's strong balance sheet allows for capital returns to shareholders. The stock currently trades for just 0.67 times annualized billings and 4.5 times normalized FCF.
MarketWise shares have fallen nearly 30% since the announcement of the resignation of its CEO. There is high uncertainty regarding the outcome of the turnaround that was taking place to return the business to profitable growth. Despite the risks involved, I believe the MKTW stock's cheap valuation, coupled with net cash representing half its market cap, presents an attractive risk-reward setup to go Long.